MD SB382 | 2016 | Regular Session
Status
Spectrum: Slight Partisan Bill (Republican 14-6)
Status: Introduced on January 28 2016 - 25% progression, died in chamber
Action: 2016-02-24 - Hearing 2/24 at 1:00 p.m.
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 28 2016 - 25% progression, died in chamber
Action: 2016-02-24 - Hearing 2/24 at 1:00 p.m.
Text: Latest bill text (Introduced) [PDF]
Summary
Requiring that specified authorized providers and prescribers be registered with the Prescription Drug Monitoring Program before obtaining a specified new or renewal registration or by July 1, 2017, whichever is sooner; requiring that specified pharmacists be registered with the Program by a certain date; requiring specified prescribers and pharmacists to request and assess specified drug monitoring data under specified circumstances; etc.
Title
Prescription Drug Monitoring Program - Revisions
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2016-02-24 | Senate | Hearing 2/24 at 1:00 p.m. |
| 2016-01-28 | Senate | Motion Rules Suspended Rule 32 (Senator Klausmeier) Adopted |
| 2016-01-28 | Senate | First Reading Finance |
Subjects
Assisted Living
Committees and Commissions
Controlled Dangerous Substances
Developmental Disabilities
Discipline
Disclosure
Diseases
Drugs
Health Occupations
Hospices
Hospitals
Licenses
Long-Term Care
Pharmacists and Pharmacies
Privacy
Public Health
Public Information
Records
Registration
Reports
Rules and Regulations
Substance Abuse
Telecommunications and Information Technology
Committees and Commissions
Controlled Dangerous Substances
Developmental Disabilities
Discipline
Disclosure
Diseases
Drugs
Health Occupations
Hospices
Hospitals
Licenses
Long-Term Care
Pharmacists and Pharmacies
Privacy
Public Health
Public Information
Records
Registration
Reports
Rules and Regulations
Substance Abuse
Telecommunications and Information Technology
